Scholarlink

<p>Biofilms formed by <i>Staphylococcus aureus</i> and <i>Staphylococcus epidermidis</i> form structurally complex, matrix-encased communities, and the resulting infections are among the most difficult to treat. Bacteria embedded within these biofilms show markedly reduced antibiotic susceptibility, reflecting increased tolerance rather than classical resistance, so that doses lethal to planktonic cells are frequently ineffective. The regulatory network responsible for biofilm formation is tightly linked to virulence regulation; thus, disrupting one often disrupts the other. SpoVG (Stage V sporulation protein G), the central node in this network, is a small transcriptional regulator whose full regulatory scope remains incompletely understood. This review highlights SpoVG’s function in <i>Staphylococcus</i>, including its regulation of the expression of the adhesion factor gene <i>sasC</i> and the thermonuclease (<i>nuc</i>). Moreover, SpoVG enhances PIA biosynthesis via the <i>ica</i> operon, thereby promoting assembly of biofilm matrix proteins and down-regulating the <i>agr</i> quorum-sensing system, inhibiting toxin synthesis. Overall, these actions enable SpoVG to act as a molecular rheostat that influences biofilm formation and reduces acute virulence in response to environmental signals. Importantly, this dual nature of SpoVG makes it highly promising in translational applications. Unlike traditional antibiotic targets, SpoVG is dispensable for bacterial survival, which may lower, though not eliminate, the selective pressure that drives resistance development. Several natural and artificial products have also been discovered that have the potential to inhibit SpoVG-mediated signaling pathways. They can either alter SpoVG expression directly or involve nodes at other levels within the pathway. The article concludes with an assessment of the current ambiguities and the critical measures that need to be taken by scientists to translate their findings into therapeutics.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Stage V sporulation protein G as a global regulator of biofilm formation and virulence in Staphylococcus species: molecular mechanisms and therapeutic potential

  • 期刊论文

  • 发表日期：

    2026年7月23日

查看全文
  • Abirami Karthikeyan,
  • Aqib Javaid,
  • Grace Naa Ayorkor Charway,
  • Nazia Tabassum,
  • Tae-Hee Kim,
  • Young-Mog Kim,
  • Won-Kyo Jung,
  • Fazlurrahman Khan

摘要

Biofilms formed by Staphylococcus aureus and Staphylococcus epidermidis form structurally complex, matrix-encased communities, and the resulting infections are among the most difficult to treat. Bacteria embedded within these biofilms show markedly reduced antibiotic susceptibility, reflecting increased tolerance rather than classical resistance, so that doses lethal to planktonic cells are frequently ineffective. The regulatory network responsible for biofilm formation is tightly linked to virulence regulation; thus, disrupting one often disrupts the other. SpoVG (Stage V sporulation protein G), the central node in this network, is a small transcriptional regulator whose full regulatory scope remains incompletely understood. This review highlights SpoVG’s function in Staphylococcus, including its regulation of the expression of the adhesion factor gene sasC and the thermonuclease (nuc). Moreover, SpoVG enhances PIA biosynthesis via the ica operon, thereby promoting assembly of biofilm matrix proteins and down-regulating the agr quorum-sensing system, inhibiting toxin synthesis. Overall, these actions enable SpoVG to act as a molecular rheostat that influences biofilm formation and reduces acute virulence in response to environmental signals. Importantly, this dual nature of SpoVG makes it highly promising in translational applications. Unlike traditional antibiotic targets, SpoVG is dispensable for bacterial survival, which may lower, though not eliminate, the selective pressure that drives resistance development. Several natural and artificial products have also been discovered that have the potential to inhibit SpoVG-mediated signaling pathways. They can either alter SpoVG expression directly or involve nodes at other levels within the pathway. The article concludes with an assessment of the current ambiguities and the critical measures that need to be taken by scientists to translate their findings into therapeutics.